Related Experiment Video
Updated: Jul 16, 2026

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice
Tsuyoshi Chiba1, Shohei Shinozaki2, Toru Nakazawa2
1Vascular Medicine and Geriatrics, Department of Medicine, Tokyo Medical and Dental University, Graduate School, Yushima 1-5-45, Bunkyo-ku, Tokyo 113-8519, Japan; Ochanomizu University, Institute of Environmental Science for Human Life, Ohtsuka 2-1-1, Bunkyo-ku, Tokyo 112-8610, Japan.
Abstract:
Both experimental and epidemiological studies suggest that leptin is one of the molecules responsible for accelerated atherosclerosis in obese humans. To confirm the notion, we studied whether leptin accelerates atherosclerosis in apoE(-/-) mice. Leptin deficient hyperlipidemic mice (ob/ob;apoE(-/-) mice) developed significantly less atherosclerosis than apoE(-/-) mice, when fed an atherogenic diet for 16 weeks from 8 weeks of age. Histological analysis revealed that most of the atherosclerotic lesions in ob/ob;apoE(-/-) mice remained as fatty streaks, while those in apoE(-/-) mice were mainly fibrous plaques. The decrease in atherosclerosis was not due to changes in the serum levels of cholesterol, TNF-alpha, or adiponectin. Exogenous leptin significantly increased atherosclerotic areas in apoE(-/-) mice, even though it decreased food intake and body weight. Our findings support the notion that leptin accelerates atherosclerosis.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Inflammation
